Rapid and efficient generation of neurons from Charcot-Marie-Tooth disease (CMT2A) patient IPSCS

被引:0
|
作者
De La Cruz-Sevilla, Josue [1 ]
Zhou, Yueqin [2 ,3 ]
Bell, Shaughn [2 ,3 ]
Baloh, Robert [2 ,3 ,4 ]
机构
[1] Calif State Univ Long Beach, CSULongBeach CIRM Stem Cell Internship, Long Beach, CA 90840 USA
[2] Cedars Sinai Med Ctr, Ctr Neural Sci & Med, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA
[4] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA
关键词
CMT2A; MFN2; iPSC; Inducible Differentiation; Neurons;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
455
引用
收藏
页码:135 / 135
页数:1
相关论文
共 50 条
  • [1] Altered Lipid Biosynthesis in Charcot-Marie-Tooth Disease Type 2A (CMT2A)
    Zuchner, Stephan
    NEUROLOGY, 2011, 76 (09) : A454 - A455
  • [2] Modeling Charcot-Marie-Tooth disease using patient iPSCs
    Ohara, R.
    Imamura, K.
    Morii, F.
    Egawa, N.
    Mizuno, T.
    Nakagawa, M.
    Inoue, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 860 - 861
  • [3] Mutation analysis of the CMT2A locus in Charcot-Marie-Tooth type 2 cases
    Züchner, S
    Mersiyanova, IV
    Senderek, J
    Polyakov, AV
    Dadali, EL
    Bergmann, C
    Schröder, JM
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S64 - S64
  • [4] Charcot-Marie-Tooth (CMT) disease: an update
    Vallat, Jean-Michel
    Funalot, Benoit
    M S-MEDECINE SCIENCES, 2010, 26 (10): : 842 - 847
  • [5] Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A
    Saito, M
    Hayashi, Y
    Suzuki, T
    Tanaka, H
    Hozumi, I
    Tsuji, S
    NEUROLOGY, 1997, 49 (06) : 1630 - 1635
  • [6] NEPHROPATHY ASSOCIATED WITH CHARCOT-MARIE-TOOTH (CMT) DISEASE
    GUILLOT, M
    GUBLER, MC
    AICARDI, J
    BROYER, M
    LANDTHALER, G
    PARAIN, D
    INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 1985, 6 (03): : 232 - 232
  • [7] Linkage mapping and clinico-pathological findings of Charcot-Marie-Tooth disease type 2A (CMT2A)
    Saito, M
    Hayashi, Y
    Suzuki, T
    Tanaka, H
    Tsuji, S
    NEUROLOGY, 1997, 48 (03) : 5094 - 5094
  • [8] Patient-specific iPSCs recapitulate the disease signatures of Charcot-Marie-Tooth type 2
    Van Lent, Jonas
    Juneja, Manisha
    Verstraelen, Peter
    Asselbergh, Bob
    Verbist, Christophe
    Timmerman, Vincent
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 476 - 476
  • [9] Anticipation in Charcot-Marie-Tooth disease type 2 (CMT2)
    Vinci, P
    Oliveira, GR
    Antenor, JA
    Thomas, FP
    NEUROLOGY, 2001, 56 (08) : A324 - A325
  • [10] Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease
    Fledrich, Robert
    Stassart, Ruth M.
    Sereda, Michael W.
    BRITISH MEDICAL BULLETIN, 2012, 102 (01) : 89 - 113